These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enteric-coated and plain naproxen tablets in osteoarthritis; tolerability and efficacy. Lehn OF, Jensen ON, Andersen LA, Christensen KA, Solheim L, Barslev J, Mjølstad W, Wiig G, Ibfelt HH, Kjønniksen T. Eur J Rheumatol Inflamm; 1992; 12(2):31-6. PubMed ID: 1364936 [Abstract] [Full Text] [Related]
4. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations. Huskisson EC, Bernstein RM, Coppock JS, Davies PG, Doyle DV, Platt PR, Scott DL, Witherington RH, Wojtulewski JA. Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935 [Abstract] [Full Text] [Related]
5. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group. Caldwell JR, Roth SH. J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394 [Abstract] [Full Text] [Related]
7. Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis. Bellamy N, Beaulieu A, Bombardier C, Esdaile J, Huang S, Jovaisas AV, Khanna VN, Kraag G, Mehta DM, Ménard HA. Curr Med Res Opin; 1992 Apr; 12(10):652-61. PubMed ID: 1633723 [Abstract] [Full Text] [Related]
9. Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis. Boussina I, Vischer TL. Pharmatherapeutica; 1987 Apr; 5(1):16-20. PubMed ID: 3602020 [Abstract] [Full Text] [Related]
11. Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis. Verbruggen LA, Cytryn E, Pintens H. J Int Med Res; 1982 Apr; 10(4):214-8. PubMed ID: 7117678 [Abstract] [Full Text] [Related]
17. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials. Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC. Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620 [Abstract] [Full Text] [Related]